Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025)

Siga Technologies (SIGA) reported Total Non-Current Liabilities of $18.0 million for Q4 2025, down 28.97% on a YoY basis from $25.3 million in Q4 2024, and down 27.57% quarter-over-quarter from $24.8 million in Q3 2025.

Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Siga Technologies has reported Total Non-Current Liabilities for 16 years, with the latest figure at $18.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 28.97% year-over-year to $18.0 million; the trailing twelve-month figure through Dec 2025 stood at $18.0 million (down 28.97% YoY), and the FY2025 full-year result was $18.0 million, down 28.97% from the prior year.
  • Total Non-Current Liabilities for Q4 2025 stood at $18.0 million, down from $24.8 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $74.8 million in Q1 2024, with the low at $10.4 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $26.0 million across 5 years, with a median of $22.5 million in 2021.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 304.9% — and 2025, when it sank 62.84%.
  • Siga Technologies' Total Non-Current Liabilities stood at $33.9 million in 2021, then sank by 36.51% to $21.5 million in 2022, then surged by 151.5% to $54.1 million in 2023, then slumped by 53.19% to $25.3 million in 2024, then dropped by 28.97% to $18.0 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $18.0 million (Q4 2025), $24.8 million (Q3 2025), and $22.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Siga Technologies 310.79 Mn 155.83 Mn - 17.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.99 Mn
Sep 30, 2025 24.84 Mn
Jun 30, 2025 22.72 Mn
Mar 31, 2025 27.80 Mn
Dec 31, 2024 25.33 Mn
Sep 30, 2024 22.30 Mn
Jun 30, 2024 21.38 Mn
Mar 31, 2024 74.81 Mn
Dec 31, 2023 54.12 Mn
Sep 30, 2023 30.74 Mn
Jun 30, 2023 18.99 Mn
Mar 31, 2023 18.48 Mn
Dec 31, 2022 21.52 Mn
Sep 30, 2022 27.46 Mn
Jun 30, 2022 20.17 Mn
Mar 31, 2022 10.64 Mn
Dec 31, 2021 33.89 Mn
Sep 30, 2021 22.66 Mn
Jun 30, 2021 13.25 Mn
Mar 31, 2021 10.36 Mn